Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis

Table 5

Comparison of sensitivity and specificity of anti-MCV, anti-CCP, and RF from different countries.

	Malaysia [12]	Netherlands [20]	Turkey [21]	Tunisia [7]	Oman	𝑃 value
Sensitivity (%)
Anti-MCV	80	57	49.8	74.1	72	0.04
Anti-CCP	71	50	60.2	72.4	52	0.13
RF	80	47.7	67.8	65.9	57	0.055
Specificity (%)
Anti-MCV	59.5	78.4	91.6	79	87	0.106
Anti-CCP	94.8	88.4	98.8	96.1	97	0.95
RF	74.5	86.1	91.6	74.4	94	0.39

Anti-MCV: mutated citrullinated vimentin, anti-CCP: anti-cyclic citrullinated peptide, RF: Rheumatoid Factor, RA: rheumatoid arthritis.